ES2124995T3 - Epoxidos esteroides para el tratamiento del cancer. - Google Patents

Epoxidos esteroides para el tratamiento del cancer.

Info

Publication number
ES2124995T3
ES2124995T3 ES95902957T ES95902957T ES2124995T3 ES 2124995 T3 ES2124995 T3 ES 2124995T3 ES 95902957 T ES95902957 T ES 95902957T ES 95902957 T ES95902957 T ES 95902957T ES 2124995 T3 ES2124995 T3 ES 2124995T3
Authority
ES
Spain
Prior art keywords
group
atoms
carbon
alcoxide
hydroxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95902957T
Other languages
English (en)
Inventor
Chihiro Yokoo
Hisaya Wada
Hidemichi Mitome
Tatsuhiko Sano
Katsuo Hatayama
Yasuji Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2124995T3 publication Critical patent/ES2124995T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE SUMINISTRAN NUEVOS DERIVADOS ESTEROIDES QUE TIENEN ACCION ANTITUMORAL QUE PUEDEN SINTETIZARSE EFICIENTEMENTE Y ESTEREOSELECTIVAMENTE POR MEDIO DE QUIMICA ORGANICA SINTETICA. SE PRESENTA UN DERIVADO ESTEROIDE REPRESENTADO POR LA FORMULA (I) EN LA QUE R ES UN GRUPO DE ALQUILO DE ENTRE 1 Y 13 ATOMOS DE CARBONO, A ES UN GRUPO DE HIDROXILO O UN GRUPO FACILMENTE HIDROLIZABLE EN UN GRUPO DE HIDROXILO, X E Y FORMAN JUNTAS UN GRUPO DE OXO O UN GRUPO DE ALQUILENODIOXIDO QUE TIENE ENTRE 2 Y 3 ATOMOS DE CARBONO, X ES UN GRUPO DE HIDROXILO, UN GRUPO DE ALCOXIDO QUE TIENE ENTRE 1 Y 5 ATOMOS DE CARBONO O UN GRUPO FACILMENTE HIDROLIZABLE EN UN GRUPO DE HIDROXILO, Y ES UN ATOMO DE HIDROGENO O UN GRUPO DE ALCOXIDO QUE TIENE ENTRE 1 Y 5 ATOMOS DE CARBONO, CON LA CONDICION DE QUE CUANDO X SEA UN GRUPO DE HIDROXILO O UN GRUPO FACILMENTE HIDROLIZABLE EN UN GRUPO DE HIDROXILO, Y ES UN ATOMO DE HIDROGENO, Y CUANDO X SEA UN GRUPO DE ALCOXIDO QUE TENGA ENTRE 1 Y 5 ATOMOS DE CARBONO, Y ES UN GRUPO DE ALCOXIDO QUETIENE ENTRE 1 Y 5 ATOMOS DE CARBONO. TAMBIEN SE PRESENTA UNA SAL DEL DERIVADO.
ES95902957T 1993-12-15 1994-12-14 Epoxidos esteroides para el tratamiento del cancer. Expired - Lifetime ES2124995T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31524693 1993-12-15
PCT/JP1994/002102 WO1995016699A1 (fr) 1993-12-15 1994-12-14 Derive de steroide

Publications (1)

Publication Number Publication Date
ES2124995T3 true ES2124995T3 (es) 1999-02-16

Family

ID=18063133

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95902957T Expired - Lifetime ES2124995T3 (es) 1993-12-15 1994-12-14 Epoxidos esteroides para el tratamiento del cancer.

Country Status (9)

Country Link
US (1) US5712263A (es)
EP (1) EP0735047B1 (es)
AT (1) ATE173271T1 (es)
AU (1) AU679302B2 (es)
CA (1) CA2178900A1 (es)
DE (1) DE69414602T2 (es)
DK (1) DK0735047T3 (es)
ES (1) ES2124995T3 (es)
WO (1) WO1995016699A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372712B1 (en) 1998-05-22 2002-04-16 The Board Of Trustees Of The Leland Stanford Jr. University Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122521A (en) * 1990-07-17 1992-06-16 Taisho Pharmaceutical Co., Ltd. Sterol compound

Also Published As

Publication number Publication date
DE69414602D1 (de) 1998-12-17
DE69414602T2 (de) 1999-04-08
EP0735047A1 (en) 1996-10-02
US5712263A (en) 1998-01-27
EP0735047A4 (en) 1996-11-27
ATE173271T1 (de) 1998-11-15
DK0735047T3 (da) 1999-07-26
AU1200395A (en) 1995-07-03
EP0735047B1 (en) 1998-11-11
AU679302B2 (en) 1997-06-26
CA2178900A1 (en) 1995-06-22
WO1995016699A1 (fr) 1995-06-22

Similar Documents

Publication Publication Date Title
ES2092589T3 (es) Cierre para recipiente con un cuerpo de cierre perforable.
CO5261589A1 (es) Compuestos heterociclicos, su produccion y su utilizacion
ES2078775T3 (es) Tinta, proceso para la impresion por chorros de tinta que utiliza la misma y aparato correspondiente.
ES2124995T3 (es) Epoxidos esteroides para el tratamiento del cancer.
SE7612053L (sv) Forfarande for framstellning av enolderivat
ES2191963T3 (es) Derivados triciclicos de triazolobenzazepina, proceso para la obtencion de los mismos y agentes antialergicos.
ES2142642T3 (es) Dispersiones de poliuretano acuosas latentemente reticulantes.
ES2086144T3 (es) Catalizador para la hidrolisis de sulfuro de carbonilo.
ES2008087B3 (es) Montaje de tope de desembrague reversible, en especial para vehiculo automovil.
ES2082205T3 (es) Aparato aplicador de cualquier producto liquido.
FR2277897A1 (fr) Procede de recuperation du gallium de solutions tres basiques par extraction liquide/liquide
GB1387175A (en) Salts of iodomethanesulphonic acid
GB245861A (en) An improved book-rest or holder
PH16357A (en) Indole and indoline derivatives and its pharmaceutical compositions
GB191311439A (en) Improvements in or relating to the Attaching of Door Knobs to Spindles.
GB945909A (en) Morphinone and codeinone derivatives
AU3047001A (en) Polycyclic dianthraquinones as anti-cancer and anti-angiogenic agents
GR74870B (es)
Hamp Locative Singular in"-ei"[Greek]
AU1423788A (en) 6-oxoprostaglandin-E derivatives, process for their production and their pharmaceutical application
GB1106100A (en) Novel 4,5-epoxy-9ª‰,10ª‡-steroids
US1164339A (en) Curtain-holder.
GB191416129A (en) Improvements in or relating to Shaving-stick Casings.
GB519701A (en) Improvements in and relating to door checking and door holding device
CO4230085A1 (es) Derivados de tetrahidropirano

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 735047

Country of ref document: ES